Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZA Combined with R-GemOx for Elderly DLBCL
NCT06778902Phase 2Not yet recruiting
- Start
- Feb 2025
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azacitidine in diffuse large B-cell lymphoma (DLBCL). Planned start Feb 2025; status: not yet recruiting.
02
Drugs
azacitidine
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT06778902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06778902.